COVID-19: NAFDAC confirms COVISHIELD same as Astrazeneca vaccine

The National Agency for Food And Drug Administration and Control (NAFDAC) has confirmed that AstraZeneca and Oxford University (AZOU) originally developed the ChAdOx1 recombinant adenoviral vector vaccine to be used for the prevention of COVID-19 disease.

This is contained in a statement issued on Sunday signed by the agency’s Director-General, Prof Mojisola Adeyeye, on Sunday, in Abuja.

Adeyeye explained that AZOU gave the license of its vaccine to Serum Institute of India PVT Ltd (SIIPL) to manufacture this vaccine at a commercial scale.

“SIIPL is the largest vaccine manufacturer in the world and the company got the license by signing a manufacturing agreement with AstraZeneca (AZ)/Oxford University to manufacture this vaccine.

“SIIPL gave the vaccine the trade name COVISHIELDTM. COVISHIELDTM is the result of cooperation and a technology transfer from the AstraZeneca University of Oxford to SIIPL,” she said.

Adeyeye further explained that Serum Institute of India Pvt. Ltd. is now the world’s largest vaccine manufacturer by a number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines.

She stressed that vaccines manufactured by the Serum Institute are accredited by the World Health Organisation, Geneva and are being used in around 170 countries across the globe in their national immunisation programs, saving millions of lives throughout the world.

“Both COVISHIELD manufactured by Serum Institute of India Pvt Ltd and COVID-19 Vaccine AstraZeneca manufactured by AstraZeneca are the same vaccine – ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).

“COVISHIELDTM was granted Emergency Use Listing (EUL) by the World Health Organisation on February 15, 2021 and it is one of the listed vaccines under the COVAX Facility,” she said.

YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE

COVID-19: Nigeria Close To ‘Flattening The Curve’ ― Analysis

Nigeria may be close to flattening the curve of the COVID-19 pandemic as confirmed cases in the country keep dropping weekly, Tribune Online analysis has shown. This is even as the much-expected COVID-19 vaccines arrived in Abuja, the Federal Capital Territory last Tuesday…COVID-19: NAFDAC confirms COVISHIELD same as Astrazeneca vaccine

COVID-19: NAFDAC confirms COVISHIELD same as Astrazeneca vaccine

You might also like
Comments

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More